首页
400-620-6333
小分子和化合物库
选项
-
硫酸奎宁荧光标准物质分子式: C40H48N4O4.H2SO4.2H2O 分子量: 782.95IUPAC Name: (R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol;sulfuric acid;dihydrateSMILES: COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O.COC1=CC2=C(C=CN=C2C=C1)C(C3CC4CCN3CC4C=C)O.O.O.OS(=O)(=O)OInChIKey: ZHNFLHYOFXQIOW-LPYZJUEESA-NInChI: See more
-
四螨嗪CAS号: 74115-24-5 EC号: 277-728-2分子式: C14H8Cl2N4 分子量: 303.15IUPAC Name: 3,6-bis(2-chlorophenyl)-1,2,4,5-tetrazineSMILES: C1=CC=C(C(=C1)C2=NN=C(N=N2)C3=CC=CC=C3Cl)ClInChIKey: UXADOQPNKNTIHB-UHFFFAOYSA-NInChI: 1S/C14H8Cl2N4/c15-11-7-3-1-5-9(11)13-17-19-14(20-18-13)10-6-2-4-8-12(10)16/h1-8H
-
L-异亮氨酸-15NCAS号: 59935-30-7分子式: C6H1315NO2 分子量: 132.17IUPAC Name: (2S,3S)-2-(15N)azanyl-3-methylpentanoic acidSMILES: CCC(C)C(C(=O)O)NInChIKey: AGPKZVBTJJNPAG-NNXLWEQRSA-NInChI: 1S/C6H13NO2/c1-3-4(2)5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t4-,5-/m0/s1/i7+1
-
-
L-丙氨酸-15NCAS号: 25713-23-9分子式: C3H715NO2 分子量: 90.09IUPAC Name: (2S)-2-(15N)azanylpropanoic acidSMILES: CC(C(=O)O)NInChIKey: QNAYBMKLOCPYGJ-GZPBOPPUSA-NInChI: 1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6)/t2-/m0/s1/i4+1
-
α-L-天冬酰胺-15N 一水合物CAS号: 204451-47-8分子式: C4H815NNO3· H2O 分子量: 151.13IUPAC Name: 2,4-diamino-4-oxobutanoic acid;hydrateSMILES: C(C(C(=O)O)N)C(=O)N.OInChIKey: RBMGJIZCEWRQES-UHFFFAOYSA-NInChI: 1S/C4H8N2O3.H2O/c5-2(4(8)9)1-3(6)7;/h2H,1,5H2,(H2,6,7)(H,8,9);1H2
-
Belantamab mafodotin (anti-BCMA)关联靶标: TNFRSF17简短描述: Purity≥90% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG1; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Conjugated (MC-VC-PAB-MMAF)种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey) 亚型: Human IgG1宿主种属: 人(Human) 偶联: MC-VC-PAB-MMAFCAS号: 2050232-20-5SMILES: [Belantamab mafodotin]
-
Lifastuzumab vedotin (anti-SLC34A2)关联靶标: SLC34A2简短描述: Purity≥90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (MC-VC-PAB-MMAE)种属反应性: 人(Human) 亚型: Human IgG1宿主种属: 人(Human) 偶联: MC-VC-PAB-MMAECAS号: 1401812-88-1
-
Lorvotuzumab mertansine (anti-NCAM1)关联靶标: NCAM1简短描述: Purity>90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (SMCC-DM1)种属反应性: 人(Human) 亚型: Human IgG1宿主种属: 人(Human) 偶联: SMCC-DM1CAS号: 1008106-64-6
-
Lutikizumab (anti-IL1a&IL1b)简短描述: Purity≥90% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human), 小鼠(Mouse), 食蟹猴(Cynomolgus monkey) 亚型: Human IgG1宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1791411-57-8
-
Labetuzumab govitecan (anti-CEACAM5)关联靶标: CEACAM5简短描述: Purity>90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (CL2A-SN-38)种属反应性: 人(Human), 小鼠(Mouse), 食蟹猴(Cynomolgus monkey) 亚型: Human IgG1宿主种属: 人(Human) 偶联: CL2A-SN-38CAS号: 1469876-18-3 Compound CID : 91668184SMILES: See more
-
Ozoralizumab (anti-TNF-alpha&HSA)简短描述: Purity≥90% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human)宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1167985-17-2
